Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / News/  Biological E reduces slashes price of its Covid vaccine Corbevax
BackBack

Biological E reduces slashes price of its Covid vaccine Corbevax

Biological E. has developed India’s first indigenous sub-unit covid-19 against the novel coronavirus

Previously, in private vaccination centres the overall cost to end users of the vaccine was ₹990 a dose, including taxes and administration charges (HT)Premium
Previously, in private vaccination centres the overall cost to end users of the vaccine was 990 a dose, including taxes and administration charges (HT)

Hyderabad based pharmaceuticals firm Biological E. Ltd (BE) today said it has reduced the price of its COVID-19 vaccine Corbevax to 250 from 840 a dose, inclusive of GST, for private vaccination centres. The company in a statement said that the reduction in price will result in end users paying a price of 400 a dose which will include the taxes and administration charges. Previously, in private vaccination centres the overall cost to end users of the vaccine was 990 a dose, including taxes and administration charges, it added.

"BE has lowered the price of its vaccine with the aim of making it more affordable and help increase the reach to protect the maximum number of children against the virus," the company said.

Biological E. has developed India’s first Indigenous Sub-unit COVID-19 against the novel coronavirus. Last month the company said that it has manufactured 30 crore doses of Corbevax and have already supplied nearly 10 crore doses to the Government of India. Currently, over 3 crore doses of Corbevax have been administered in children between 12-15 years of age.

In March this year when the inoculation of children in the age group of 12 to 14 years against COVID-19 commenced in the country, Corbevax vaccine was used and its price was fixed at 145 for government vaccination programme.

In April this year India's drug regulator had granted Emergency Use Authorisation (EUA) for Biological E's Corbevax for children in 5 to 12 years group along with Bharat Biotech's Covaxin for children in the age group of 6 to 12 years.

BE had collaborated with Texas Children's Hospital and Baylor College of Medicine in the development of Corbevax. Prior to receiving EUA for vaccination, the company said it conducted Phase II and III multi-centre clinical trials in 624 children aged 5-12 and 12-18.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 16 May 2022, 01:42 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie